Serotain® Scores Almost 70% on SSRI Bioassay

WAYNE, New Jersey – Friday, July 29, 2005 -- SEROTAIN SCORES ALMOST 70% ON SSRI (Selective Serotonin Reuptake Inhibition) BIOASSAY. "This is not the first time we've had results like this," said Dr. Mark Anderson, Director of Research and Development at Triarco. "We test every lot before its release, to ensure a score of over 50%," he said. Abdullah Kelker, Director of Quality Assurance and Quality Control at Triarco, added "samples from each and every lot are sent to two different independent labs to be tested for Peak-X. Additionally, if both laboratories do not return negative results - we simply will not release them for sale." He continued by stating that "through my career with Triarco, I have never seen it test positive from the material made at the company's extraction facility in Green Pond, South Carolina."

Serotain is a proprietary extract of Griffonia seeds, yielding 5 hydroxy tryptophan. Low levels of serotonin have been linked to anxiety, insomnia, and an overactive appetite. That's why we call Serotain - "The Common Thread®," said Dr. Anderson. The ingredients in Serotain help to elevate mood, suppress appetite, and induce sleep without the negative side effects of prescription drugs.

These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.